Posted on 29 March 2021
Longevity briefs provides a short summary of novel research in biology, medicine, or biotechnology that caught the attention of our researchers in Oxford, due to its potential to improve our health, wellbeing, and longevity.
Dr. Fahy is a world renowned cryobiologist and is also the chief science officer, and co-founder, of Intervene Immune, a company which pioneers treatments for thymus regeneration and age-related immune system decline.. In this short extract from Chris’s discussion with Dr. Fahy, explains what the thymus is and its role in the ageing process.
In this talk, Dr. Fahy discusses the results from his personal long-term health journey, his current work, and how he plans to improve human health and longevity.
His pilot study on reversing immune system ageing was the first to provide conclusive evidence that aging could be reversed in humans. Using that evidence Dr. Fahy’s company Intervene Immune, Inc. is expanding this pilot study to a Phase 2 clinical trial where he will be enrolling 85 participants between 40 and 80 years old. The clinical trial is called the Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial (TRIIM-X), and it aims to use a personalised combination of somatropin, metformin, and DHEA to regrow the participant’s thymus.
Watch the full conversation talk with Greg here.
Copyright © Gowing Life Limited, 2023 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.
You must be logged in to post a comment.